271 related articles for article (PubMed ID: 29799975)
21. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.
Bonaca MP; Scirica BM; Sabatine MS; Jarolim P; Murphy SA; Chamberlin JS; Rhodes DW; Southwick PC; Braunwald E; Morrow DA
J Am Coll Cardiol; 2012 Jul; 60(4):332-8. PubMed ID: 22813612
[TBL] [Abstract][Full Text] [Related]
22. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
Elbarasi E; Goodman SG; Yan RT; Welsh RC; Kornder J; Wong GC; Déry JP; Anderson F; Gore JM; Fox KA; Yan AT; ;
Am Heart J; 2010 Jan; 159(1):40-6. PubMed ID: 20102865
[TBL] [Abstract][Full Text] [Related]
23. Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome.
Hess PL; Wojdyla DM; Al-Khatib SM; Lokhnygina Y; Wallentin L; Armstrong PW; Roe MT; Ohman EM; Harrington RA; Alexander JH; White HD; Van de Werf F; Piccini JP; Held C; Aylward PE; Moliterno DJ; Mahaffey KW; Tricoci P
JAMA Cardiol; 2016 Apr; 1(1):73-9. PubMed ID: 27437658
[TBL] [Abstract][Full Text] [Related]
24. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
Lim KD; Yan AT; Casanova A; Yan RT; Mendelsohn A; Jolly S; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2008 Apr; 155(4):718-24. PubMed ID: 18371482
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
[TBL] [Abstract][Full Text] [Related]
26. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era.
Onda T; Inoue K; Suwa S; Nishizaki Y; Kasai T; Kimura Y; Fukuda K; Okai I; Fujiwara Y; Matsuoka J; Sumiyoshi M; Daida H
Int J Cardiol; 2016 Sep; 219():180-5. PubMed ID: 27327504
[TBL] [Abstract][Full Text] [Related]
27. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.
Wenzl FA; Kraler S; Ambler G; Weston C; Herzog SA; Räber L; Muller O; Camici GG; Roffi M; Rickli H; Fox KAA; de Belder M; Radovanovic D; Deanfield J; Lüscher TF
Lancet; 2022 Sep; 400(10354):744-756. PubMed ID: 36049493
[TBL] [Abstract][Full Text] [Related]
28. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
[TBL] [Abstract][Full Text] [Related]
29. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
Elbarouni B; Ismaeil N; Yan RT; Fox KA; Connelly KA; Baer C; DeYoung JP; Gallo R; Ramanathan K; Pesant Y; Leiter LA; Goodman SG; Yan AT
Am Heart J; 2011 Aug; 162(2):347-355.e1. PubMed ID: 21835297
[TBL] [Abstract][Full Text] [Related]
30. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
32. Risk stratification and prognostic value of GRACE and TIMI risk scores for female patients with non-ST segment elevation acute coronary syndrome.
Zhu H; Xue H; Wang H; Chen Y; Zhou S; Tian F; Hu S; Wang J; Yang J; Zhang T
Minerva Cardioangiol; 2015 Jun; 63(3):171-8. PubMed ID: 25501977
[TBL] [Abstract][Full Text] [Related]
33. Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome.
Taglieri N; Dall'Ara G; Rapezzi C; Saia F; Cinti L; Rosmini S; Alessi L; Vagnarelli F; Moretti C; Palmerini T; Marrozzini C; Montefiori M; Branzi A; Marzocchi A
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):430-7. PubMed ID: 22772600
[TBL] [Abstract][Full Text] [Related]
34. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
[TBL] [Abstract][Full Text] [Related]
35. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
Lefebvre CW; Hoekstra J
Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
[TBL] [Abstract][Full Text] [Related]
36. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients.
García-Salas JM; Tello-Montoliu A; Manzano-Fernández S; Casas-Pina T; López-Cuenca A; Pérez-Berbel P; Puche-Morenilla C; Martínez-Hernández P; Valdés M; Marín F
Int J Clin Pract; 2014 Mar; 68(3):294-303. PubMed ID: 24372920
[TBL] [Abstract][Full Text] [Related]
39. Derivation and validation of a simple inflammation-based risk score system for predicting in-hospital mortality in acute coronary syndrome patients.
González-Pacheco H; Bojalil R; Amezcua-Guerra LM; Sandoval J; Eid-Lidt G; Arias-Mendoza A; Azar-Manzur F; Álvarez-Sangabriel A; Altamirano-Castillo A; Briseño-Cruz JL; Carrillo-Vega J; Vazquez-Rangel A; Abbate A; Gomez-Arroyo J; Martínez-Sánchez C
J Cardiol; 2019 May; 73(5):416-424. PubMed ID: 30600191
[TBL] [Abstract][Full Text] [Related]
40. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
